Early Response to Chemotherapy in Patients With Non–Small-Cell Lung Cancer Assessed by [18F]-Fluoro-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography-Reference-Cited by-同舟云学术

Early Response to Chemotherapy in Patients With Non–Small-Cell Lung Cancer Assessed by [18F]-Fluoro-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography

Published:2013-05 Issue:3 Volume:14 Page:230-237
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Novello Silvia,Vavalà Tiziana,Levra Matteo Giaj,Solitro Federica,Pelosi Ettore,Veltri Andrea,Scagliotti Giorgio V.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference56 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2012

2. Surveillance, Epidemiology and End Results: SEER Stat Fact Sheets: Lung and Bronchus. Available at Accessed: December 12, 2012

3. American Society of Clinical Oncology Clinical Practice guideline update on chemotherapy for stage IV non–small-cell lung cancer;Azzoli;J Clin Oncol,2009

4. Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma;Hellwig;J Thorac Cardiovasc Surg,2004

5. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: Is [18F]FDG-PET a valid alternative to conventional diagnostic methods?;Spaepen;J Clin Oncol,2001

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA;Cancers;2022-05-18

2. Efficacy of Camrelizumab in Advanced Non-Small-Cell Lung Cancer and Prognostic Analysis of Different PET/CT Features;Journal of Oncology;2022-03-25

3. Targeting HSP90 Inhibits Proliferation and Induces Apoptosis Through AKT1/ERK Pathway in Lung Cancer;Frontiers in Pharmacology;2022-01-14

4. Association between 18F-FDG metabolic activity and programmed death ligand-1 (PD-L1) expression using 22C3 immunohistochemistry assays in non-small cell lung cancer (NSCLC) resection specimens;The British Journal of Radiology;2021-03-01

5. Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922;Cells;2019-09-28